Aamna Atta | Biotechnology | Best Researcher Award

Ms. Aamna Atta | Biotechnology | Best Researcher Award

Ms. Aamna Atta, Research Assistant, Dalian Medical University, China.

Aamna Atta is a dedicated researcher and academic from Pakistan, currently pursuing her Ph.D. in Biotechnology at Dalian Medical University, China. With a solid academic foundation and hands-on experience in molecular immunology, gene recombination technology, and pathophysiology, she has made significant strides in biomedical sciences. Aamna is known for her research on gut microbiota, inflammation, and polysaccharide-based therapeutics. Alongside research, she has gained teaching experience across prestigious institutions in Pakistan and China. Her passion for biotechnology, evident in both academic and laboratory settings, has positioned her as a rising scholar in molecular biosciences and therapeutic development.

Publication Profile

ORCID

🎓 Education Background

Aamna Atta’s academic journey reflects her strong commitment to life sciences. She is currently enrolled in a Ph.D. program in Biotechnology at Dalian Medical University (2019–2025), focusing on molecular immunology and gene recombination. Earlier, she earned her M.S. in Biotechnology (2016–2019) from the International Islamic University Islamabad, where she mastered gene manipulation and molecular genetics. She also holds an M.Sc. in Botany (2013–2015) and a B.Sc. (2011–2013) from the University of Sargodha. Her foundation was built at BISE Sargodha through F.Sc. and Matric in biology. This academic portfolio laid the groundwork for her molecular biology and research career.

💼 Professional Experience

Aamna Atta has accumulated rich academic and lab experience across multiple institutions. She currently works as a Teaching Assistant at Dalian Medical University, teaching biology to undergraduates. Her earlier roles include lecturer at the University of Sargodha (2022), and teaching assistant at Quaid-i-Azam University and IIUI (2016–2018). She also completed a research internship at Pakistan Thalassemia Centre and gained two years of lab experience at the Applied Biotechnology and Genetic Engineering Lab at IIUI under Dr. Nyla Jabeen. Aamna’s roles have included teaching, assisting in research projects, and organizing academic workshops, showcasing her commitment to education and science.

🏆 Awards and Honors

Aamna Atta has consistently demonstrated academic excellence and leadership throughout her career. Although formal awards are not listed, her accomplishments include organizing multiple successful seminars and workshops at the International Islamic University Islamabad. Her hands-on participation in academia, including serving as an event organizer and lab assistant, highlights her dedication to both research and student engagement. Securing a Ph.D. opportunity at Dalian Medical University itself is a significant recognition of her capabilities. Her continued publication in high-impact journals further underlines her growing reputation in the scientific community and positions her for future honors and international recognition.

🔬 Research Focus

Aamna’s research primarily focuses on molecular immunology, gut-liver axis regulation, and gene recombination technologies. Her recent work centers on how natural polysaccharides from mushrooms and medicinal plants modulate gut microbiota, restore immune homeostasis, and protect against colitis and inflammation. With expertise in genetic engineering techniques, PCR optimization, and microbiota analysis, she aims to develop non-invasive therapeutic strategies. Aamna also explores bioactive compounds’ roles in regulating oxidative stress and liver protection. Her interdisciplinary research bridges molecular biology, pharmacology, and biotechnology to uncover new therapies for gastrointestinal and inflammatory diseases through natural compounds and gene-based solutions.

🧾 Conclusion

Aamna Atta exemplifies a promising researcher in molecular biotechnology, combining academic strength, teaching experience, and impactful research. Her dedication to gut microbiota research and molecular immunology contributes to developing novel therapeutic approaches. With a strong foundation from prestigious Pakistani institutions and international exposure in China, Aamna is well-equipped to advance in academia and research. Her professional path reflects resilience, innovation, and scientific curiosity. As she continues to publish and contribute to the biotechnology field, Aamna is poised to make notable contributions to health sciences and inspire future scholars in her domain.

📚 Top Research Publications

  1. Agrocybe cylindracea Polysaccharides Ameliorate DSS-Induced Colitis by Restoring Intestinal Barrier Function and Reprogramming Immune Homeostasis via the Gut-Liver Axis
    Journal: International Journal of Molecular Sciences (2023)
    Cited by: 32 articles

  2. Lyophyllum decastes-derived polysaccharides alleviate DSS-induced colitis in mice by suppressing inflammation, enhancing intestinal barrier integrity, and restoring gut microbiota homeostasis
    Journal: Frontiers in Pharmacology (2023)
    Cited by: 21 articles

  3. Combination of Withania coagulans and Fagonia cretica ameliorates hyperuricemia by re-modulating gut microbiota-derived spermidine and traumatic acid
    Journal: Phytomedicine (Accepted, 2024)

  4. Bioactive Peptide Hydrolysates from Vespa orientalis Pupae Modulate the Gut–Lung Axis and Inhibit NF-κB Signaling in Enterococcus faecalis LTA-Induced Pneumonia
    Journal: Biomedicine & Pharmacotherapy (Submitted, 2024)

  5. Hepatoprotective Potential of Polysaccharides from Golden Chanterelle Mushroom (Cantharellus cibarius Fr.) Against Inflammation and Oxidative Stress in DSS-Induced Liver Injury
    Journal: Journal of Future Foods (Submitted, 2024)

  6. Gut microbiota modulation and anti-inflammatory effects of Hypsizygus marmoreus polysaccharides in cisplatin-induced intestinal mucositis
    Journal: Molecules (Submitted, 2024)

 

 

Dr. Mohun Ramratnam | Biotechnology | Best Researcher Award

Dr. Mohun Ramratnam | Biotechnology | Best Researcher Award

Associate Professor, University of Wisconsin, United States

Dr. Mohun Ramratnam is a highly respected Associate Professor of Cardiovascular Medicine at the University of Wisconsin School of Medicine and Public Health. With deep expertise in interventional cardiology, he also serves as the Director of Interventional Cardiology at the William S. Middleton VA Hospital in Madison, WI. Known for his translational research and patient-centered care, Dr. Ramratnam brings a wealth of clinical and academic experience to the field of cardiovascular medicine. His journey spans multiple prestigious institutions, and he continues to shape future cardiologists through his teaching, research, and clinical leadership.

Publication Profile

Scopus

🎓 Education Background:

Dr. Ramratnam earned dual B.A. degrees in Business Economics from Brown University in 1999. He completed his M.D. at the Feinberg School of Medicine, Northwestern University in 2004. Following this, he pursued residency training in Internal Medicine at Johns Hopkins Hospital (2004–2007) and a Cardiology Fellowship at the University of Pittsburgh Medical Center (2008–2011). He further specialized through Interventional Cardiology fellowships and research training at UPMC from 2011 to 2013. He holds certifications in internal medicine, cardiovascular disease, nuclear cardiology, echocardiography, cardiac catheterization, ACLS, and BLS.

💼 Professional Experience:

Dr. Ramratnam began his career as a research assistant and associate before transitioning into medicine. He has held instructional and faculty positions at UPMC and later moved to the University of Wisconsin, where he served as Assistant Professor (2013–2021) and currently as Associate Professor. Since 2013, he has directed Interventional Cardiology services at the William S. Middleton VA Hospital. His professional memberships include the American Heart Association, American College of Cardiology, and Society for Cardiovascular Angiography and Interventions.

🏆 Awards and Honors:

He graduated Cum Laude from Phillips Academy Andover in 1995, earned Alpha Omega Alpha honors at Northwestern in 2004, and has received several prestigious research awards, including the Pittsburgh Young Investigator Award (1st Place Oral Presentation, 2012) and the BCVS Travel Award for Young Investigators. His educational and research excellence has been consistently recognized throughout his academic career.

🔬 Research Focus:

Dr. Ramratnam’s research is focused on cardioprotection and mitochondrial function in cardiovascular disease. He explores innovative mechanisms such as sulfonylurea receptor variants and the role of mitochondrial potassium channels (ROMK) in cardiomyopathy. His funded research includes VA CDA-2 Awards and pilot grants from NIH and UW-Madison. His work seeks to develop novel therapies that target mitochondrial pathways to reduce heart disease severity.

📝 Conclusion:

Blending clinical expertise with cutting-edge research, Dr. Mohun Ramratnam stands as a thought leader in interventional cardiology and cardiovascular research. With numerous peer-reviewed publications and a commitment to translational science, he continues to push the boundaries of heart disease treatment and prevention, contributing meaningfully to academic medicine and public health.

📚 Top Publications 

Transgenic knockdown of cardiac sodium/glucose cotransporter 1 attenuates PRKAG2 cardiomyopathy…
Journal of the American Heart Association, 2014
Cited by 100+ articles
Key discovery linking SGLT1 modulation to cardiac function.

Gene-Targeted Mice with the Human Troponin T R141W Mutation Develop Dilated Cardiomyopathy…
PLoS ONE, 2016
Cited by 60+ articles
Studied mutation impact on cardiomyopathy and calcium signaling.

Transgenic overexpression of the SUR2A-55 splice variant in mouse heart…
Heliyon, 2018
Cited by 50+ articles
Important in demonstrating mitochondrial protective mechanisms.

Cardiac-specific deletion of the sulfonylurea receptor 2 enhances glucose uptake…
JACC: Basic to Translational Science, 2019
Cited by 70+ articles
Showed that deletion of SUR2 can be cardioprotective.

Identification of Intrastent Pathology Associated with Late Stent Thrombosis Using OCT
Journal of Interventional Cardiology, 2015
Cited by 80+ articles
Applied optical coherence tomography to identify stent complications.